Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;28(4):308-313.
doi: 10.1089/hum.2017.048.

AAV: An Overview of Unanswered Questions

Kenneth I Berns  1 , Nicholas Muzyczka  1
Affiliations
Review

AAV: An Overview of Unanswered Questions

Kenneth I Berns et al. Hum Gene Ther. 2017 Apr.

Abstract

AAV has been studied for 55 years and has been developed as a vector for about 35 years. By now, there is a fairly good idea of the dimensions of what would be useful to know to employ AAV optimally as a vector, but there are still many unanswered questions within the system. As with all biological systems, each good experiment raises further questions to answer. This article provides an overview of those areas in which unknown information can be identified and of those questions that have not yet been recognized. Some of these are touched on in the six review articles in this issue of Human Gene Therapy.

Keywords: AAV cell interactions; AAV immunity; AAV persistence; AAV toxicity.

PubMed Disclaimer

Conflict of interest statement

K.I.B. has no conflicts of interest to declare. N.M. is a founder of Applied Genetic Technologies Corporation (AGTC) and Lacerta Therapeutics. Both companies are involved in commercializing AAV vectors for various clinical applications.

References

    1. Kay M, Valdamanis P. Future of rAAV gene therapy: platform for RNAi, gene editing and beyond. Hum Gen Ther 2017;28:361–372 - PMC - PubMed
    1. Bryant LM, Christopher DM, Giles AR, et al. . Lessons learned from the clinical development and market authorization of Glybera. Hum Gene Ther Clin Dev 2013;24:55–64 - PMC - PubMed
    1. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 1988;62:1963–1973 - PMC - PubMed
    1. Samulski RJ, Berns KI, Tan M, Muzyczka N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 1982;79:2077–2081 - PMC - PubMed
    1. Hermonat PL, Muzyczka N. Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 1984;81:6466–6470 - PMC - PubMed